Wellington Management Group LLP 4 D Molecular Therapeutics, Inc. Transaction History

Wellington Management Group LLP

$557 Billion
Q3 2024

A detailed history of Wellington Management Group LLP transactions in 4 D Molecular Therapeutics, Inc. stock. As of the latest transaction made, Wellington Management Group LLP holds 166,190 shares of FDMT stock, worth $965,563. This represents 0.0% of its overall portfolio holdings.

Number of Shares

166,190

Previous 179,444 7.39%

Holding current value

$965,563

Previous $3.77 Million 52.31%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$10.81 - $27.22 $143,275 - $360,773	-13,254 Reduced 7.39%	166,190 $1.8 Million
Q2 2024 Aug 13, 2024	BUY	$20.93 - $30.01 $205,030 - $293,977	9,796 Added 5.77%	179,444 $3.77 Million
Q1 2024 May 15, 2024	BUY	$17.03 - $35.87 $2.89 Million - $6.09 Million	169,648 New	169,648 $5.4 Million
Q4 2023 Feb 12, 2024	BUY	$9.76 - $21.25 $1.76 Million - $3.84 Million	180,475 New	180,475 $3.66 Million
Q3 2023 Nov 14, 2023	BUY	$12.64 - $19.76 $45,984 - $71,886	3,638 Added 2.15%	172,722 $2.2 Million
Q2 2023 Aug 14, 2023	SELL	$15.16 - $23.26 $97,509 - $149,608	-6,432 Reduced 3.66%	169,084 $3.06 Million
Q1 2023 May 12, 2023	SELL	$15.45 - $23.19 $1.32 Million - $1.98 Million	-85,188 Reduced 32.68%	175,516 $3.02 Million
Q4 2022 Feb 13, 2023	SELL	$6.85 - $25.46 $35,537 - $132,086	-5,188 Reduced 1.95%	260,704 $5.79 Million
Q3 2022 Nov 14, 2022	BUY	$6.96 - $11.48 $998,815 - $1.65 Million	143,508 Added 117.26%	265,892 $2.14 Million
Q1 2022 May 16, 2022	SELL	$13.16 - $22.64 $1.84 Million - $3.16 Million	-139,563 Reduced 53.28%	122,384 $1.85 Million
Q4 2021 Feb 11, 2022	BUY	$19.56 - $32.94 $5.12 Million - $8.63 Million	261,947 New	261,947 $5.75 Million
Q2 2021 Aug 16, 2021	SELL	$22.2 - $42.29 $2 Million - $3.82 Million	-90,251 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$35.94 - $52.67 $4.27 Million - $6.26 Million	-118,928 Reduced 56.85%	90,251 $3.91 Million
Q4 2020 Feb 12, 2021	BUY	$38.43 - $47.36 $8.04 Million - $9.91 Million	209,179 New	209,179 $8.67 Million

Others Institutions Holding FDMT

# of Institutions

144

Shares Held

57.7M

Call Options Held

137K

Put Options Held

111K

View Full List

About 4D Molecular Therapeutics, Inc.

Ticker FDMT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,382,400
Market Cap $188M
Description
4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical tr...

More about FDMT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.

Account

Wellington Management Group LLP 4 D Molecular Therapeutics, Inc. Transaction History